Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study

Abstract Background The role of beta-blockers in acute myocardial infarction patients without heart failure and with preserved left ventricular ejection fraction (LVEF ≥ 50%) is unknown. Our study aimed to retrospectively analyze the associations of beta-blockers on such patients. Methods This is a...

Full description

Bibliographic Details
Main Authors: Xue-song Wen, Rui Luo, Jie Liu, Qin Duan, Shu Qin, Jun Xiao, Dong-Ying Zhang
Format: Article
Language:English
Published: BMC 2022-04-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-022-02631-8
_version_ 1828370833158963200
author Xue-song Wen
Rui Luo
Jie Liu
Qin Duan
Shu Qin
Jun Xiao
Dong-Ying Zhang
author_facet Xue-song Wen
Rui Luo
Jie Liu
Qin Duan
Shu Qin
Jun Xiao
Dong-Ying Zhang
author_sort Xue-song Wen
collection DOAJ
description Abstract Background The role of beta-blockers in acute myocardial infarction patients without heart failure and with preserved left ventricular ejection fraction (LVEF ≥ 50%) is unknown. Our study aimed to retrospectively analyze the associations of beta-blockers on such patients. Methods This is a multicenter, retrospective study. After screening 5,332 acute myocardial infarction patients, a total of 2519 patients without heart failure and with LVEF ≥ 50% were included. The patients were divided into two groups: the prescribed (n = 2049) and unprescribed (n = 470) beta-blockers group. The propensity score inverse probability treatment weighting was used to control confounding factors. We analyzed the associations between beta-blockers and outcomes in the short-term (1-year) and long-term (median, 3.61 years). Results The primary outcome was all-cause mortality. The secondary outcomes were all-cause rehospitalization, cardiac death, recurrent myocardial infarction, new-onset heart failure rehospitalization. This study shows no statistically significant association between discharged with beta-blockers and all-cause mortality, either in the short-term [IPTW Adjusted, HR 1.02; 95%CI 0.43–2.40; P = 0.966] or long-term [IPTW Adjusted, HR 1.17; 95%CI 0.70–1.94; P = 0.547]. Discharged with beta-blockers was significantly associated with a reduced risk of short-term recurrent myocardial infarction [IPTW Adjusted, HR 0.44; 95%CI 0.20–0.97; P = 0.043], but there was no long-term relationship [IPTW Adjusted, HR 1.11; 95%CI 0.61–2.03; P = 0.735]. Other outcomes, such as new-onset heart failure rehospitalization and all-cause rehospitalization, were not observed with meaningful differences in either the short- or long-term. The results of sensitivity analysis were consistent with this. Conclusions Beta-blockers might be associated with a reduced risk of recurrent myocardial infarction in patients without heart failure and with preserved left ventricular ejection fraction after acute myocardial infarction, in the short term. Beta-blockers might not be related to all-cause mortality in those patients, either in the short-term or long-term. Clinical trial registration Influence of Beta-blockers on Prognosis in Patients with Acute Myocardial Infarction Complicated with Normal Ejection Fraction, NCT04485988, Registered on 24/07/2020. Retrospectively registered.
first_indexed 2024-04-14T06:43:21Z
format Article
id doaj.art-d28c5a08cbb44648a054a0b69f2d9172
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-04-14T06:43:21Z
publishDate 2022-04-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-d28c5a08cbb44648a054a0b69f2d91722022-12-22T02:07:16ZengBMCBMC Cardiovascular Disorders1471-22612022-04-0122111110.1186/s12872-022-02631-8Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort studyXue-song Wen0Rui Luo1Jie Liu2Qin Duan3Shu Qin4Jun Xiao5Dong-Ying Zhang6Department of Cardiovascular Medicine, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Cardiovascular Medicine, The First Branch of the First Affiliated Hospital of Chongqing Medical UniversityDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Chongqing Medical UniversityDepartment of Cardiovascular Medicine, Chongqing University Center HospitalDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Chongqing Medical UniversityAbstract Background The role of beta-blockers in acute myocardial infarction patients without heart failure and with preserved left ventricular ejection fraction (LVEF ≥ 50%) is unknown. Our study aimed to retrospectively analyze the associations of beta-blockers on such patients. Methods This is a multicenter, retrospective study. After screening 5,332 acute myocardial infarction patients, a total of 2519 patients without heart failure and with LVEF ≥ 50% were included. The patients were divided into two groups: the prescribed (n = 2049) and unprescribed (n = 470) beta-blockers group. The propensity score inverse probability treatment weighting was used to control confounding factors. We analyzed the associations between beta-blockers and outcomes in the short-term (1-year) and long-term (median, 3.61 years). Results The primary outcome was all-cause mortality. The secondary outcomes were all-cause rehospitalization, cardiac death, recurrent myocardial infarction, new-onset heart failure rehospitalization. This study shows no statistically significant association between discharged with beta-blockers and all-cause mortality, either in the short-term [IPTW Adjusted, HR 1.02; 95%CI 0.43–2.40; P = 0.966] or long-term [IPTW Adjusted, HR 1.17; 95%CI 0.70–1.94; P = 0.547]. Discharged with beta-blockers was significantly associated with a reduced risk of short-term recurrent myocardial infarction [IPTW Adjusted, HR 0.44; 95%CI 0.20–0.97; P = 0.043], but there was no long-term relationship [IPTW Adjusted, HR 1.11; 95%CI 0.61–2.03; P = 0.735]. Other outcomes, such as new-onset heart failure rehospitalization and all-cause rehospitalization, were not observed with meaningful differences in either the short- or long-term. The results of sensitivity analysis were consistent with this. Conclusions Beta-blockers might be associated with a reduced risk of recurrent myocardial infarction in patients without heart failure and with preserved left ventricular ejection fraction after acute myocardial infarction, in the short term. Beta-blockers might not be related to all-cause mortality in those patients, either in the short-term or long-term. Clinical trial registration Influence of Beta-blockers on Prognosis in Patients with Acute Myocardial Infarction Complicated with Normal Ejection Fraction, NCT04485988, Registered on 24/07/2020. Retrospectively registered.https://doi.org/10.1186/s12872-022-02631-8Beta-blockersAcute myocardial infarctionHeart failureLeft ventricular ejection fraction
spellingShingle Xue-song Wen
Rui Luo
Jie Liu
Qin Duan
Shu Qin
Jun Xiao
Dong-Ying Zhang
Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study
BMC Cardiovascular Disorders
Beta-blockers
Acute myocardial infarction
Heart failure
Left ventricular ejection fraction
title Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study
title_full Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study
title_fullStr Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study
title_full_unstemmed Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study
title_short Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study
title_sort short term long term prognosis with or without beta blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction a multicenter retrospective cohort study
topic Beta-blockers
Acute myocardial infarction
Heart failure
Left ventricular ejection fraction
url https://doi.org/10.1186/s12872-022-02631-8
work_keys_str_mv AT xuesongwen shorttermlongtermprognosiswithorwithoutbetablockersinpatientswithoutheartfailureandwithpreservedejectionfractionafteracutemyocardialinfarctionamulticenterretrospectivecohortstudy
AT ruiluo shorttermlongtermprognosiswithorwithoutbetablockersinpatientswithoutheartfailureandwithpreservedejectionfractionafteracutemyocardialinfarctionamulticenterretrospectivecohortstudy
AT jieliu shorttermlongtermprognosiswithorwithoutbetablockersinpatientswithoutheartfailureandwithpreservedejectionfractionafteracutemyocardialinfarctionamulticenterretrospectivecohortstudy
AT qinduan shorttermlongtermprognosiswithorwithoutbetablockersinpatientswithoutheartfailureandwithpreservedejectionfractionafteracutemyocardialinfarctionamulticenterretrospectivecohortstudy
AT shuqin shorttermlongtermprognosiswithorwithoutbetablockersinpatientswithoutheartfailureandwithpreservedejectionfractionafteracutemyocardialinfarctionamulticenterretrospectivecohortstudy
AT junxiao shorttermlongtermprognosiswithorwithoutbetablockersinpatientswithoutheartfailureandwithpreservedejectionfractionafteracutemyocardialinfarctionamulticenterretrospectivecohortstudy
AT dongyingzhang shorttermlongtermprognosiswithorwithoutbetablockersinpatientswithoutheartfailureandwithpreservedejectionfractionafteracutemyocardialinfarctionamulticenterretrospectivecohortstudy